View More View Less
  • 1 National Institute of Environmental Health Risk Assessment Department Gyáli út 2-6 H-1097 Budapest Hungary
  • 2 Szent István University Department and Clinic of Internal Medicine, Faculty of Veterinary Science Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $836.00

In a study of 44 canine patients suffering from histopathologically proven urinary bladder tumour with a high incidence of transitional cell carcinoma (TCC) (n = 35), a close relationship was found either between the disease-free period and the age (r = −0.40) of animals or between the survival times and the age (r = −0.62) of animals after treatment. In addition to the dog breeds known to be prone to have urinary bladder tumour, we found an additional potentially sensitive breed, the Hungarian Vizsla. The median survival times obtained by the applied treatment types were as follow: ‘surgery and chemotherapy’ (n = 8/44) 475 days, ‘surgery alone’ (n = 19/44) 240 days, ‘chemotherapy alone’ (n = 7/44) 31 days, and ‘no treatment’ (n = 10/44) 7 days (P < 0.001). According to the findings, chemotherapy combined with surgery completed in time is the most effective protocol in the treatment of urinary bladder tumour cases in dogs. A rational and more effective procedure for the assessment and treatment of urinary bladder tumour cases is presented.

  • Benigni, L., Lamb, C. R., Corzo-Menendez, N., Holloway, A. and Eastwood, J. M. (2006): Lymphoma affecting the urinary bladder in three dogs and a cat. Vet. Radiol. Ultrasound. 47, 592–596.

    Eastwood J. M. , 'Lymphoma affecting the urinary bladder in three dogs and a cat ' (2006 ) 47 Vet. Radiol. Ultrasound. : 592 -596.

    • Search Google Scholar
  • Bellmunt, J., Albiol, S., Suárez, C. and Albanell, J. (2009): Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agents. Oncol. Hematol. 69, 211–222.

    Albanell J. , 'Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agents ' (2009 ) 69 Oncol. Hematol. : 211 -222.

    • Search Google Scholar
  • Boria, P. A., Glickman, N. W., Schmidt, B. R., Widmer, W. R., Mutsaers, A. J., Adams, L. G., Snyder, P. W., DiBernardi, L., de Gortari, A. E., Bonney, P. L. and Knapp, D. W. (2005): Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet. Comp. Oncol. 3, 73–80.

    Knapp D. W. , 'Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder ' (2005 ) 3 Vet. Comp. Oncol. : 73 -80.

    • Search Google Scholar
  • Chun, R., Knapp, D. W., Widmer, W. R., DeNicola, D. B., Glickman, N. W., Kuczek, T., Degortari, A. and Han, C. M. (1997): Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J. Vet. Intern. Med. 11, 279–283.

    Han C. M. , 'Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder ' (1997 ) 11 J. Vet. Intern. Med. : 279 -283.

    • Search Google Scholar
  • Chun, R., Knapp, D. W., Widmer, W. R., Glickman, N. W., DeNicola, D. B. and Bonney, P. L. (1996): Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983–1993). J. Am. Vet. Med. Assoc. 209, 1588–1591.

    Bonney P. L. , 'Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983–1993) ' (1996 ) 209 J. Am. Vet. Med. Assoc. : 1588 -1591.

    • Search Google Scholar
  • Dahl, K., Karlsson, M., Marits, P., Hoffstedt, A., Winqvist, O. and Thörn, M. (2008): Sentinel node — the first lymph node draining a metastasis — contains tumor-reactive lymphocytes. Ann. Surg. Oncol. 15, 1454–1463.

    Thörn M. , 'Sentinel node — the first lymph node draining a metastasis — contains tumor-reactive lymphocytes ' (2008 ) 15 Ann. Surg. Oncol. : 1454 -1463.

    • Search Google Scholar
  • Greene, S. N., Lucroy, M. D., Greenberg, C. B., Bonney, P. L. and Knapp, D. W. (2007): Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. J. Am. Vet. Med. Assoc. 231, 1056–1060.

    Knapp D. W. , 'Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder ' (2007 ) 231 J. Am. Vet. Med. Assoc. : 1056 -1060.

    • Search Google Scholar
  • Glickman, L. T., Schofer, F. S., McKee, L. J., Reif, J. S. and Goldschmidt, M. H. (1989): Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J. Toxicol. Environ. Health. 28, 407–414.

    Goldschmidt M. H. , 'Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs ' (1989 ) 28 J. Toxicol. Environ. Health. : 407 -414.

    • Search Google Scholar
  • Hall, M. C., Chang, S. S., Dalbagni, G., Pruthi, R. S., Seigne, J. D., Skinner, E. C., Wolf, J. S. Jr. and Schellhammer, P. F. J. (2007): Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J. Urol. 178, 2314–2330.

    Schellhammer P. F. J. , 'Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update ' (2007 ) 178 J. Urol. : 2314 -2330.

    • Search Google Scholar
  • Hammer, A. S., Couto, C. G., Ayl, R. D. and Shank, K. A. (1994): Treatment of tumor-bearing dogs with actinomycin D. J. Vet. Intern. Med. 8, 236–239.

    Shank K. A. , 'Treatment of tumor-bearing dogs with actinomycin D ' (1994 ) 8 J. Vet. Intern. Med. : 236 -239.

    • Search Google Scholar
  • Hayes, H. M. Jr., Hoover, R. and Tarone, R. E. (1981): Bladder cancer in pet dogs: a sentinel for environmental cancer? Am. J. Epidemiol. 114, 229–233.

    Tarone R. E. , 'Bladder cancer in pet dogs: a sentinel for environmental cancer? ' (1981 ) 114 Am. J. Epidemiol. : 229 -233.

    • Search Google Scholar
  • Henry, C. J., McCaw, D. L., Turnquist, S. E., Tyler, J. W., Bravo, L., Sheafor, S., Straw, R. C., Dernell, W. S., Madewell, B. R., Jorgensen, L., Scott, M. A., Higginbotham, M. L. and Chun, R. (2003): Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin. Cancer Res. 9, 906–911.

    Chun R. , 'Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma ' (2003 ) 9 Clin. Cancer Res. : 906 -911.

    • Search Google Scholar
  • Knapp, D. W., Glickman, N. W., DeNicola, D. B., Bonney, P. L., Lin, T. L. and Glickman, L. T. (2000a): Naturally-occurring canine transitional cell carcinoma of the urinary bladder — A relevant model of human invasive bladder cancer. Urol. Oncol. 5, 47–59.

    Glickman L. T. , 'Naturally-occurring canine transitional cell carcinoma of the urinary bladder — A relevant model of human invasive bladder cancer ' (2000 ) 5 Urol. Oncol. : 47 -59.

    • Search Google Scholar
  • Knapp, D. W., Glickman, N. W., Widmer, W. R., DeNicola, D. B., Adams, L. G., Kuczek, T., Bonney, P. L., DeGortari, A. E., Han, C. and Glickman, L. T. (2000b): Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother. Pharmacol. 46, 221–226.

    Glickman L. T. , 'Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer ' (2000 ) 46 Cancer Chemother. Pharmacol. : 221 -226.

    • Search Google Scholar
  • Lengerich, E. J., Teclaw, R. F., Mendlein, M., Mariolis, P. and Garbe, P. L. (1992): Pet populations in the catchment area of the Purdue Comparative Oncology Program. J. Am. Vet. Med. Assoc. 200, 51–56.

    Garbe P. L. , 'Pet populations in the catchment area of the Purdue Comparative Oncology Program ' (1992 ) 200 J. Am. Vet. Med. Assoc. : 51 -56.

    • Search Google Scholar
  • Moore, A. S., Cardona, A., Shapiro, W. and Madewell, B. R. (1990): Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs. J. Vet. Intern. Med. 4, 148–152.

    Madewell B. R. , 'Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs ' (1990 ) 4 J. Vet. Intern. Med. : 148 -152.

    • Search Google Scholar
  • Mueller, C. M., Caporaso, N. and Greene, M. H. (2008): Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol. Oncol. 26, 451–464.

    Greene M. H. , 'Familial and genetic risk of transitional cell carcinoma of the urinary tract ' (2008 ) 26 Urol. Oncol. : 451 -464.

    • Search Google Scholar
  • Norris, A. M., Laing, E. J., Valli, V. E., Withrow, S. J., Macy, D. W., Ogilvie, G. K., Tomlinson, J., McCaw, D., Pidgeon, G. and Jacobs, R. M. (1992): Canine bladder and urethral tumors: a retrospective study of 115 cases (1980–1985). J. Vet. Intern Med. 6, 145–153.

    Jacobs R. M. , 'Canine bladder and urethral tumors: a retrospective study of 115 cases (1980–1985) ' (1992 ) 6 J. Vet. Intern Med. : 145 -153.

    • Search Google Scholar
  • Ogilvie, G. K., Obradovich, J. E., Elmslie, R. E., Vail, D. M., Moore, A. S., Straw, R. C., Dickinson, K., Cooper, M. F. and Withrow, S. J. (1991): Efficacy of mitoxantrone against various neoplasms in dogs. J. Am. Vet. Med. Assoc. 198, 1618–1621.

    Withrow S. J. , 'Efficacy of mitoxantrone against various neoplasms in dogs ' (1991 ) 198 J. Am. Vet. Med. Assoc. : 1618 -1621.

    • Search Google Scholar
  • Ogilvie, G. K., Reynolds, H. A., Richardson, R. C., Withrow, S. J., Norris, A. M., Henderson, R. A., Klausner, J. S., Fowler, J. D. and McCaw, D. (1989): Phase II evaluation of doxorubicin treatment of various canine neoplasms. J. Am. Vet. Med. Assoc. 195, 1580–1583.

    McCaw D. , 'Phase II evaluation of doxorubicin treatment of various canine neoplasms ' (1989 ) 195 J. Am. Vet. Med. Assoc. : 1580 -1583.

    • Search Google Scholar
  • Patrick, D. J., Fitzgerald, S. D., Sesterhenn, I. A., Davis, C. J. and Kiupel, M. (2006): Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification. J. Comp. Pathol. 135, 190–199.

    Kiupel M. , 'Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification ' (2006 ) 135 J. Comp. Pathol. : 190 -199.

    • Search Google Scholar
  • Poirier, V. J., Forrest, L. J., Adams, W. M. and Vail, D. M. (2004): Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J. Am. Anim. Hosp. Assoc. 40, 131–136.

    Vail D. M. , 'Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study ' (2004 ) 40 J. Am. Anim. Hosp. Assoc. : 131 -136.

    • Search Google Scholar
  • Raghavan, D. (2003): Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder. Urol. Oncol. 21, 468–474.

    Raghavan D. , 'Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder ' (2003 ) 21 Urol. Oncol. : 468 -474.

    • Search Google Scholar
  • Serra, C., Bonfill, X., Sunyer, J., Urrutia, G., Turuguet, D., Bastús, R., Roqué, M., ’t Mannetje, A. and Kogevinas, M. (2000): Working Group on the Study of Bladder Cancer in the County of Valles Occidental. Bladder cancer in the textile industry. Scand. J. Work Environ. Health 26, 476–481.

    Kogevinas M. , 'Working Group on the Study of Bladder Cancer in the County of Valles Occidental. Bladder cancer in the textile industry ' (2000 ) 26 Scand. J. Work Environ. Health : 476 -481.

    • Search Google Scholar
  • Shapiro, W., Kitchell, B. E., Fossum, T. W., Couto, C. G. and Theilen, G. (1988): Cisplatin for treatment of transitional cell carcinoma and squamous cell carcinomas in dogs. J. Am. Vet. Med. Assoc. 193, 1530–1533.

    Theilen G. , 'Cisplatin for treatment of transitional cell carcinoma and squamous cell carcinomas in dogs ' (1988 ) 193 J. Am. Vet. Med. Assoc. : 1530 -1533.

    • Search Google Scholar
  • Upton, M. L., Tangner, C. H. and Payton, M. E. (2006): Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. J. Am. Vet. Med. Assoc. 228, 549–552.

    Payton M. E. , 'Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma ' (2006 ) 228 J. Am. Vet. Med. Assoc. : 549 -552.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2020 0 4 2
Jul 2020 10 3 6
Aug 2020 3 0 0
Sep 2020 1 0 0
Oct 2020 6 0 0
Nov 2020 5 1 0
Dec 2020 0 0 0